Cargando…
Vagal stimulation in heart failure
Vagal nerve stimulation (VNS) has a strong pathophysiological rationale as a potentially beneficial treatment for heart failure with reduced ejection fraction. Despite several promising preclinical studies and pilot clinical studies, the two large, controlled trials—NECTAR-HF and INOVATE-HF—failed t...
Autores principales: | Dusi, Veronica, De Ferrari, Gaetano Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642334/ https://www.ncbi.nlm.nih.gov/pubmed/34716778 http://dx.doi.org/10.1007/s00059-021-05076-5 |
Ejemplares similares
-
Drug treatment of heart failure in the elderly
por: Berliner, D., et al.
Publicado: (2018) -
Key inflammatory mechanisms underlying heart failure
por: Riehle, C., et al.
Publicado: (2019) -
Common genetic predisposition for heart failure and cancer
por: Pfeffer, Tobias J., et al.
Publicado: (2020) -
Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022) -
Management strategies in heart failure with preserved ejection fraction
por: Wintrich, Jan, et al.
Publicado: (2022)